Categories: News

Denis Arsenault Acquires Additional Securities of Jushi Holdings Inc.

HERGISWIL, Switzerland, Dec. 09, 2022 (GLOBE NEWSWIRE) — Denis Arsenault (the “Acquiror“), located at Rue Sonnhaldenstrasse, 1A, Hergiswil Switzerland, 6052, announced today that on December 7, 2022, he acquired 3,452,595 warrants (the “Warrants“) of Jushi Holdings Inc. (the “Issuer”) pursuant to a private offering (the “Offering“) of the Issuer consisting of the issuance of 12% second lien notes and Warrants. Each Warrant entitles the Acquiror to acquire one subordinate voting share of the Issuer (the “Subordinate Voting Shares“) at a price of US$2.086 until December 7, 2026.

Following the completion of the acquisition of the 3,452,595 Warrants, the Acquiror holds 7,677,899 Subordinate Voting Shares and 16,702,595 Warrants, which represent in the aggregate, on an as-converted basis, approximately 11.43% of the Subordinate Voting Shares that are issued and outstanding following the completion of the Offering (calculated in accordance with National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues and on a non-diluted basis).

For further information, please contact Investor Relations, Jushi Holdings Inc., investors@jushico.com.

This press release is issued pursuant to National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues, which requires a report to be filed on SEDAR (www.sedar.com) containing additional information with respect to the foregoing matters. A copy of this report may be obtained by contacting Investor Relations, Jushi Holdings Inc., investors@jushico.com.

About Jushi Holdings Inc.
We are a vertically integrated cannabis company led by an industry leading management team. In the United States, Jushi is focused on building a multi-state portfolio of branded cannabis-derived assets through opportunistic acquisitions, distressed workouts, and competitive applications. Jushi strives to maximize shareholder value while delivering high quality products across all levels of the cannabis ecosystem. For more information, visit jushico.com or our social media channels, Instagram, Facebook, Twitter and LinkedIn.

Investor Relations Contact:
Michael Perlman
Executive Vice President of Investor Relations and Treasury
561-281-0247
Investors@jushico.com

Media Contact:

Ellen Mellody
MATTIO Communications
570-209-2947
Ellen@Mattio.com

Staff

Recent Posts

Methodist Le Bonheur Healthcare named among Best in Cancer Care by Money magazine

MEMPHIS, Tenn., July 5, 2024 /PRNewswire/ -- Methodist Le Bonheur Healthcare announced its four Memphis-based adult hospitals…

2 days ago

Hospital PMI® at 55.8%; June 2024 Hospital ISM® Report On Business®

TEMPE, Ariz., July 5, 2024 /PRNewswire/ -- Economic activity in the hospital subsector grew in June…

2 days ago

KORE Helps mCare Digital Launch the Next Generation of Personal Emergency Technology

mCare Digital unveils the mCareWatch MW-241 powered by KORE connectivity ATLANTA, July 5, 2024 /PRNewswire/…

2 days ago

Cosmo Shareholders Approved All Resolutions Proposed by the Board of Directors at Extraordinary General Meeting

Shareholders approved a dividend distribution of € 2.00 per ordinary share; representing an increase of…

2 days ago

Hitachi’s Holography Electron Microscope Attains Unprecedented Resolution

Image acquisition and defocusing correction techniques enable observations of atomic-scale magnetic fields at never-before-seen resolution…

2 days ago

Phio Pharmaceuticals Terminates Share Purchase Agreement with Triton Funds

Marlborough, Massachusetts--(Newsfile Corp. - July 5, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical…

2 days ago